Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01280357
Other study ID # MHL101801
Secondary ID
Status Completed
Phase N/A
First received January 19, 2011
Last updated March 20, 2013
Start date February 2010
Est. completion date September 2010

Study information

Verified date March 2013
Source Monica Healthcare Ltd
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Clinical Investigation Protocol for a study designed to determine the equivalence of the Monica AN24 monitor to Philips 50XM for fetal heart rate (FHR) and uterine contraction (UC) monitoring during labor. The study will be carried out on subjects in the first and second stages of labor.


Description:

The study is a prospective, randomized, single-center observational study designed to compare the Fetal Heart Rate (FHR) and Uterine Activity (UA) output data obtained by the Monica AN24 monitor during the first and second stages of labor to those generated by existing FDA-approved devices.Patients were enrolled at the facility but the patient details were removed from the results in order that the data could be randomized for the statistical analysis.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date September 2010
Est. primary completion date June 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years to 40 Years
Eligibility Inclusion Criteria:

- Pregnant, age 15-40

- Term gestation (>36 completed weeks)

- Singleton fetus

- Active labor

- Vertex presentation

- Requiring internal monitoring

Exclusion Criteria:

- Clinical contraindication for Intra Uterine Pressure Catheter

- Major fetal malformation

Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic


Intervention

Device:
Monica AN24 (K101081)
If not confident of Monica AN24 displayed data then remove Monica AN24 monitor and continue monitoring with Philips 50XM
Philips 50XM
If not confident of Monica AN24 displayed data then remove Monica AN24 monitor and continue monitoring with Philips 50XM

Locations

Country Name City State
United States Queens Hospital Center New York New York
United States Temple University Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Monica Healthcare Ltd

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Mean Positive Percentage Agreement (PPA) for Fetal Heart Between Device 1 Monica AN24 & Device 2 Philips 50XM During Labor & delivery, fetal heart rate was measured between the Monica AN24 & the Philips 50XM and the waveforms of the 2 devices were measured to see the percentage of time they were in agreement. during labor and delivery the waveforms were measured for between 35 minutes and 15 hours during the first and second stage of labour No
Primary The Mean Positive Percentage Agreement (PPA) for Maternal Heart Between Device 1 Monica AN24 & Device 2 Philips 50XM During Labor & delivery, maternal heart rate was measured between the Monica AN24 & the Philips 50XM and the waveforms of the 2 devices were measured to see the percentage of time they were in agreement. during labor and delivery the waveforms were measured for between 35 minutes and 15 hours during the first and second stage of labour No
Secondary The Mean Positive Percentage Agreement for Uterine Contractions Between the Monica AN24 & The Philips 50XM During labor and delivery uterine contractions were measured between the Monica AN24 & the philips 50XM, the waveforms of the two devices were measured to see the percentage of time they were in agreement between 35 mins & 15hrs during first & second stage labor No